[Recommendations of antifungal treatment in patients with low grade immunosuppression]. / Recomendaciones de tratamiento antifúngico en pacientes con bajo grado de inmunodepresión.
Rev Esp Quimioter
; 21(2): 127-42, 2008 Jun.
Article
en Es
| MEDLINE
| ID: mdl-18509772
Because of the relevance that the systemic mycoses has acquired in non-highly immunocompromised patients, the treatment difficulties they have due to the increase of the non-albicans Candida species and the need to have a better and more rational use of the new antifungal agents (voriconazole, posaconazole, caspofungin, anidulafungin and micafungin), an experts' panel on infectious diseases in representation of the Spanish Society of Chemotherapy, Spanish Society of Internal Medicine, and Spanish Society of Pneumology and Thoracic Surgery has met in order to make a few recommendations based on the scientific evidence in an effort to improve their efficiency.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Huésped Inmunocomprometido
/
Micosis
/
Antifúngicos
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
Es
Revista:
Rev Esp Quimioter
Asunto de la revista:
TERAPIA POR MEDICAMENTOS
Año:
2008
Tipo del documento:
Article
Pais de publicación:
España